STOCK TITAN

VersaBank (VBNK) adds Thrive Financial as new US receivable program partner

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

VersaBank filed a Form 6-K as a foreign private issuer noting that it has furnished a press release dated October 6, 2025 as Exhibit 99.1. The release is titled “VersaBank announces Thrive Financial as new US Receivable Purchase Program Partner,” highlighting a new partnership for its US receivable purchase program.

Positive

  • None.

Negative

  • None.

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of October, 2025
Commission File Number: 001-40805
VersaBank
(Exact name of registrant as specified in its charter)
140 Fullarton Street, Suite 2002
London, Ontario N6A 5P2
Canada
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F o Form 40-F x
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): o



On October 6, 2025, VersaBank issued a press release titled "VersaBank announces Thrive Financial as new US Receivable Purchase Program Partner", a copy of which is furnished as Exhibit 99.1 to this Report of Foreign Private Issuer on Form 6-K.
The information in this Form 6-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
VERSABANK
Date: October 6, 2025By:/s/ Brent T. Hodge
Name: Brent T. Hodge
Title: SVP, General Counsel & Corporate Secretary



EXHIBIT INDEX
Exhibit
No.
Description
99.1
Press Release dated October 6, 2025 titled "VersaBank announces Thrive Financial as new US Receivable Purchase Program Partner".

FAQ

What did VersaBank (VBNK) disclose in its October 2025 Form 6-K?

VersaBank disclosed that it furnished a press release dated October 6, 2025 as Exhibit 99.1. The release is titled “VersaBank announces Thrive Financial as new US Receivable Purchase Program Partner,” indicating a newly announced partnership related to its US receivable purchase program.

Who is VersaBank’s new US Receivable Purchase Program partner mentioned in the 6-K?

The Form 6-K states that VersaBank announced Thrive Financial as its new US Receivable Purchase Program partner. This information appears in the attached press release, which is furnished as Exhibit 99.1 and dated October 6, 2025, under the specified title in the filing.

When was the VersaBank press release about Thrive Financial issued?

The filing explains that VersaBank issued the press release on October 6, 2025. That press release, titled “VersaBank announces Thrive Financial as new US Receivable Purchase Program Partner,” is furnished with the Form 6-K as Exhibit 99.1 for readers to review in full.

How is the VersaBank press release about Thrive Financial presented in the Form 6-K?

The press release is furnished as Exhibit 99.1 to the Form 6-K. The filing clarifies that the information in the Form 6-K, including Exhibit 99.1, is furnished and not deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934.

Does VersaBank’s October 2025 Form 6-K incorporate the press release into other filings?

The document specifies that the information in the Form 6-K, including the press release in Exhibit 99.1, is not deemed incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, limiting its legal use in other filings.